SilicoLife secures two Series A rounds for expanding precision fermentation and microorganism engineering

In Portugal, last month SilicoLife concluded the first of two Series A rounds fundraising to the tune of €4.9 million, covered in its entirety by funds managed by venture capital firm BlueCrow.

In line with the approved objective-based program for the next 24 months, BlueCrow is committed to securing a second, equally sizable, round of investment in SilicoLife. The two rounds of investment are aimed at supporting the development and evolution of the company’s business model over the next 3 to 5 years.

SilicoLife combines AI and Biology to further the sustainable production of various ingredients, using precision fermentation and microorganism engineering. With a strong track record in creating optimized biological solutions for leading companies across different sectors of activity, SilicoLife will focus on creating its own line of production technologies within the dietary supplements industry.